Astrana Health, Inc. (NASDAQ:ASTH) Shares Bought by Wells Fargo & Company MN

Wells Fargo & Company MN boosted its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 41.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,484 shares of the company’s stock after buying an additional 6,596 shares during the period. Wells Fargo & Company MN’s holdings in Astrana Health were worth $709,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in ASTH. Principal Financial Group Inc. purchased a new stake in shares of Astrana Health during the third quarter worth approximately $13,383,000. Franklin Resources Inc. purchased a new stake in shares of Astrana Health during the third quarter worth $1,187,000. Barclays PLC acquired a new stake in shares of Astrana Health in the third quarter valued at about $4,457,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Astrana Health by 348.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company’s stock worth $1,191,000 after buying an additional 29,355 shares in the last quarter. Finally, Truist Financial Corp acquired a new position in Astrana Health during the fourth quarter worth about $315,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Trading Up 0.9 %

Shares of ASTH stock opened at $31.44 on Friday. The company has a 50-day moving average of $30.73 and a two-hundred day moving average of $37.58. The firm has a market cap of $1.58 billion, a PE ratio of 24.18, a price-to-earnings-growth ratio of 1.37 and a beta of 1.04. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. On average, analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have commented on ASTH shares. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a report on Tuesday, March 4th. Barclays initiated coverage on Astrana Health in a research report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price objective on the stock. Stifel Nicolaus dropped their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Robert W. Baird reduced their price target on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Finally, Truist Financial dropped their price objective on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a report on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Astrana Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $53.29.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.